CB Insights
Technology Market Intelligence
Technology Market Intelligence
Casdin Capital is an investment firm focused on the life sciences and healthcare industry.
1350 Avenue of the Americas
Suite 1140
New York, 10019
New York, United States
| Date | Company | Round | Amount | Co-investors |
|---|---|---|---|---|
| 2021-04-15 | C2i Genomics | Series B | $100M | Alexandria Real Estate Equities, Driehaus Capital Management, Duquesne Family Office, iGlobe Partners, Mark Foundation for Cancer Research, NFX, Section 32, and Silver Lake |
| 2021-04-14 | Multiply Labs | Series A | $20M | Fifty Years Fund, Founders Fund, Garage Capital, Lux Capital, and Pathfinder |
| 2021-04-08 | Ventus Therapeutics | Series B | $100M | Alexandria Venture Investments, BVF Partners, Cormorant Asset Management, Fonds de Solidarite FTQ, Google Ventures, RA Capital Management, and Versant Ventures |
| 2021-03-25 | Leyden Labs | Series A | $47.08M | Brook Byers, F-Prime Capital, and Google Ventures |
| 2021-03-23 | AbSci | Series F | $125M | aMoon Fund, ArrowMark Partners, D1 Capital Partners, Fidelity Investments, Irving Investors, Perceptive Advisors, and Redmile Group |
